<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01749813</url>
  </required_header>
  <id_info>
    <org_study_id>23031</org_study_id>
    <nct_id>NCT01749813</nct_id>
  </id_info>
  <brief_title>Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease</brief_title>
  <acronym>SCD</acronym>
  <official_title>Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates whether the specific carbohydrate diet (SCD) can maintain clinical&#xD;
      remission in pediatric and adult patients with Crohn's disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be seen in clinic at new diagnosis of Crohn's disease or a flare of existing&#xD;
      disease. Potential subjects will be screened with for eligibility, followed by a baseline&#xD;
      assessment by the clinic provider. Subjects who wish to participate will undergo further&#xD;
      discussion with one of the study staff. At enrollment, a member of the study staff will&#xD;
      explain the study to the prospective participant (for consent and/or assent, if applicable&#xD;
      given patient's age).&#xD;
&#xD;
      The SCD will be started in addition to previous maintenance medication therapy or with short&#xD;
      course of corticosteroids 1-2mg/kg/day (up to 60mg maximum). Steroid induction based on&#xD;
      clinical need.&#xD;
&#xD;
      We anticipate improvement in clinical symptoms, laboratory values and/or a decline in PCDAI&#xD;
      of 12.5 points (pediatric patients) or decline in CDAI of 70 points (adult patients) after 4&#xD;
      weeks. Patients who do not reach remission by 4 weeks will be excluded from the study.&#xD;
      Patients who require additional medications for disease control will be excluded from the&#xD;
      study.&#xD;
&#xD;
      Patients will be seen in clinic at diagnosis, 2 weeks (if required by clinical symptoms), 1&#xD;
      month, 3 months and 6 months.&#xD;
&#xD;
      Assessment at initial enrollment and at all follow-up visits includes:&#xD;
&#xD;
        1. History of symptoms&#xD;
&#xD;
        2. Physical exam including height, weight, BMI, Tanner staging&#xD;
&#xD;
        3. Calculation of Pediatric Crohn's Disease Activity Index (PCDAI) for pediatric patients&#xD;
           or the Crohn's Disease Activity Index (CDAI) score for adult patients.&#xD;
&#xD;
        4. Dietary assessment and nutritional counseling&#xD;
&#xD;
        5. Completion of validated quality of life measurement (IMPACT III for pediatric patients&#xD;
           and SIBDQ in adult patients)&#xD;
&#xD;
        6. Adverse event monitoring (record of symptoms and review of laboratory surveillance)&#xD;
&#xD;
        7. Laboratory assessment including: CBC with differential, basic metabolic panel, liver&#xD;
           function tests, albumin, ESR, CRP, stool calprotectin and stool lactoferrin&#xD;
&#xD;
        8. Serum sample for cytokine studies&#xD;
&#xD;
        9. Stool studies for microbiota studies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease</measure>
    <time_frame>1 year</time_frame>
    <description>The primary end point of the study is the proportion of patients achieving steroid free remission at 6 months</description>
  </primary_outcome>
  <enrollment type="Actual">8</enrollment>
  <condition>Crohn's Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children under 18 Adult&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult or pediatric patients presenting with a new diagnosis or flare of existing&#xD;
             Crohn's disease based on standard diagnostic criteria including: clinical symptoms,&#xD;
             laboratory parameters, disease activity indices (Pediatric Crohn's Disease Activity&#xD;
             Index (PCDAI) for patients &lt;19years and Crohn's Disease Activity Index (CDAI) for&#xD;
             patients &gt;19years), pathology from upper endoscopy/colonoscopy and imaging studies.&#xD;
&#xD;
        Exclusion Criteria:)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Other autoimmune conditions including celiac disease, rheumatoid arthritis, multiple&#xD;
             sclerosis&#xD;
&#xD;
          -  Otherwise immunosuppressed patients including HIV and prior organ transplant&#xD;
&#xD;
          -  Patients diagnosed with ulcerative colitis or indeterminate colitis&#xD;
&#xD;
          -  Active tuberculosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Cox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University Medical</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shamita Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University Medicial</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Burgis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://med.stanford.edu/clinicaltrials/</url>
    <description>Specific Carbohydrate Diet in Crohn's Disease</description>
  </link>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>December 12, 2012</study_first_submitted>
  <study_first_submitted_qc>December 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2012</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Jennifer Burgis</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Carbohydrate Specific Diet</keyword>
  <keyword>Crohn's Disease</keyword>
  <keyword>Immunomodulators</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

